AU3359697A - Bone resorption inhibitors - Google Patents

Bone resorption inhibitors

Info

Publication number
AU3359697A
AU3359697A AU33596/97A AU3359697A AU3359697A AU 3359697 A AU3359697 A AU 3359697A AU 33596/97 A AU33596/97 A AU 33596/97A AU 3359697 A AU3359697 A AU 3359697A AU 3359697 A AU3359697 A AU 3359697A
Authority
AU
Australia
Prior art keywords
bone resorption
resorption inhibitors
inhibitors
bone
resorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33596/97A
Inventor
Kazuhiko Aibe
Susumu Igarashi
Yasutaka Ishii
Ichio Noda
Osamu Noshiro
Yukihiro Takebayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU3359697A publication Critical patent/AU3359697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AU33596/97A 1996-07-08 1997-07-08 Bone resorption inhibitors Abandoned AU3359697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-177955 1996-07-08
JP17795596 1996-07-08
PCT/JP1997/002357 WO1998001133A1 (en) 1996-07-08 1997-07-08 Bone resorption inhibitors

Publications (1)

Publication Number Publication Date
AU3359697A true AU3359697A (en) 1998-02-02

Family

ID=16040012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33596/97A Abandoned AU3359697A (en) 1996-07-08 1997-07-08 Bone resorption inhibitors

Country Status (2)

Country Link
AU (1) AU3359697A (en)
WO (1) WO1998001133A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723407D0 (en) 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
GEP20043163B (en) 1998-03-19 2004-01-26 Vertex Pharma Inhibitors of Caspases, Pharmaceutical Composition on its Base and Method for its Production
US6902721B1 (en) * 1998-07-10 2005-06-07 Osteoscreen, Inc. Inhibitors of proteasomal activity for stimulating bone growth
US6117870A (en) 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
CZ20013248A3 (en) * 1999-03-15 2002-04-17 Axys Pharmaceuticals, Inc. Novel compounds and preparations functioning as protease inhibitors
US6469047B1 (en) 1999-09-24 2002-10-22 Genentech, Inc. Tyrosine derivatives
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB9923748D0 (en) 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
KR100468254B1 (en) 1999-12-24 2005-01-27 에프. 호프만-라 로슈 아게 Nitrile derivatives as cathepsin k inhibitors
GB0003111D0 (en) 2000-02-10 2000-03-29 Novartis Ag Organic compounds
PE20011350A1 (en) 2000-05-19 2002-01-15 Vertex Pharma PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE)
GB0025354D0 (en) 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
CA2433520A1 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
EP1436255A1 (en) 2001-09-14 2004-07-14 Aventis Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
KR20050044497A (en) 2001-11-14 2005-05-12 아벤티스 파마슈티칼스 인크. Oligopeptides and compositions containing them as cathepsin s inhibitors
EP1472222A1 (en) 2002-02-08 2004-11-03 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
WO2007046842A2 (en) * 2005-03-02 2007-04-26 Merck & Co., Inc. Composition for inhibition of cathepsin k
JP3975226B2 (en) 2006-01-11 2007-09-12 生化学工業株式会社 Cycloalkylcarbonylamino acid derivative and process for producing the same
JP4012239B2 (en) 2006-01-11 2007-11-21 生化学工業株式会社 Oxazolone derivatives
EP2036920B1 (en) 2006-01-11 2011-05-18 Seikagaku Corporation Cycloalkylcarbonylamino acid ester derivative and process for producing the same
JP4047365B2 (en) 2006-01-11 2008-02-13 生化学工業株式会社 Cycloalkanecarboxamide derivative and method for producing the same
ES2436550T3 (en) 2009-04-20 2014-01-02 F. Hoffmann-La Roche Ag New proline derivatives as cathepsin inhibitors
WO2012061785A2 (en) 2010-11-05 2012-05-10 Brandeis University Ice inhibiting compounds and uses thereof
WO2014199645A1 (en) 2013-06-14 2014-12-18 生化学工業株式会社 α-OXOACYL AMINO-CAPROLACTAM BODY
EP3009444B1 (en) 2013-06-14 2017-12-20 Seikagaku Corporation Alpha-oxoacyl amino-caprolactam derivative
US11851422B2 (en) 2021-07-09 2023-12-26 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140026A (en) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd Pharmaceutical having improved absorbability
JPS62129297A (en) * 1985-08-09 1987-06-11 Toyo Jozo Co Ltd Calcitonin gene related peptide derivative
US5055451A (en) * 1986-12-22 1991-10-08 Syntex Inc. Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors
JP3613818B2 (en) * 1994-10-06 2005-01-26 三菱ウェルファーマ株式会社 Tricoporin derivatives
ES2144788T3 (en) * 1995-12-01 2000-06-16 Hoechst Marion Roussel Inc DERIVATIVES OF ENOL ACILS OF ALPHA-KETOESTERS AND OF ALPHA-KETOAMIDS.

Also Published As

Publication number Publication date
WO1998001133A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AU3359697A (en) Bone resorption inhibitors
AU2205997A (en) Orthopedic implant
AU1224895A (en) Bone anchor
AU3380397A (en) Bone screw
AU5407598A (en) Bone implant
AU2659997A (en) Fixation devices
AU692846B2 (en) Bone plate
AU2001199A (en) Bone plate
AU6412796A (en) Osteosynthesis aid
AU4477897A (en) Orthopedic device
AU5846498A (en) Spinal implant
AU5855796A (en) Methods for inhibiting bone loss
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
AU8782798A (en) Self-clearing bone biting instrument
AU6493598A (en) Biodegradable osteosynthesis implant
AU1036697A (en) Surgical anchorage
AU4203297A (en) The use of proteinase inhibitors for prevention or reduction of bone resorption
AU3459897A (en) Differentiation inhibitor
AU1486997A (en) An agent promoting bone formation and inhibiting bone resorption
AU6043096A (en) Methods for minimizing bone loss
AUPN289395A0 (en) Intramedullary bone nail
AU7888498A (en) Carcinogenesis inhibitors
AU3254097A (en) An orthopedic bandage
AU5743396A (en) Methods for inhibiting bone loss
AU2810497A (en) Methods for inducing bone formation